Approval Actions

06
Sep

OGD Approval Actions – New High For FY 2022 (Unofficial Totals)

It appears that the OGD has hit a new high for total approval actions in August, judging by the unofficial numbers gathered from the available FDA databases as of this morning. Yes, that’s right-a total of ninety-five approval actions (seventy-four full-approval and twenty-one tentative-approval actions), which eclipses the ninety-four total full- and tentative-approval actions (eight-four […]

Read More
19
Aug

Mid-Month Peak at August 2022 ANDA Approval Actions

Well, we just passed the midway mark for August 2022 and it looks like a potentially good month for ANDA approval actions.  Thus far (at least posted through August 16th), the OGD has issued thirty full-approval actions and eleven tentative-approval actions, well on its way to a high-70s or low-to-mid-80s number of approval actions. We […]

Read More
17
Dec

December Mid-Month Generic Approval Actions Look a Bit Anemic

FDA approval actions listed through December 15th include only seventeen full‑approval actions and six tentative‑approval actions for a total of twenty‑three total approval actions.  As it stands, if these numbers represent one half of a month, it would mean that, at the current pace, we would see forty‑six total approval actions for the month of […]

Read More
17
Sep
Red Arrow Moving Down Over Graph Paper Background

September 2021 ANDA Approval Actions Slow Through the First Half of the Month

Through the last posting on the daily approval list on September 16, OGD has reported only 16 full approval actions and one tentative approval action.  If this rate keeps up through the rest of the month, we are likely to see the fewest number of monthly approval actions since the beginning of the GDUFA program. […]

Read More
1 2